Current drug therapies for Parkinson’s disease (PD) offer symptom control without the capability for disease modification. Furthermore, unpredictable on/off fluctuations and dyskinesias present challenges in titrating appropriate doses. Our study aims to utilise resting state functional MRI (fMRI) to determine the effect of PD medication, as preliminary step to future work to address these limitations.
This abstract and the presentation materials are available to members only; a login is required.